About
miRdetect develops and provides the M371-Test, a high-sensitivity liquid biopsy test that detects the miR-371a-3p microRNA biomarker in blood for the diagnosis and monitoring of testicular cancer.
Explore miRdetect's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.